Nobel committee honors tumor immunologists

Anand Rotte; Gabriella D'Orazi; Madhuri Bhandaru

doi:10.1186/s13046-018-0937-6

Nobel committee honors tumor immunologists

Anand Rotte, Gabriella D'Orazi, Madhuri Bhandaru

Istituto Regina Elena

Research output: Contribution to journal › Editorial › peer-review

Abstract

This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body's immune system to attack cancer. Their studies have led to the development of an entire class of drugs that hopefully will bring lasting remissions to many patients who had run out of options.

Original language	English
Number of pages	1
Journal	Journal of experimental & clinical cancer research : CR
Volume	37
Issue number	1
DOIs	https://doi.org/10.1186/s13046-018-0937-6
Publication status	Published - Oct 30 2018

Keywords

Anti-tumor immune response
CTLA-4
Immune checkpoints
Immunotherapy
PD-1
PD-L1

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1186/s13046-018-0937-6

Fingerprint Dive into the research topics of 'Nobel committee honors tumor immunologists'. Together they form a unique fingerprint.

Cite this

@article{3517148570324d998b2d03a7873d8bbc,

title = "Nobel committee honors tumor immunologists",

abstract = "This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body's immune system to attack cancer. Their studies have led to the development of an entire class of drugs that hopefully will bring lasting remissions to many patients who had run out of options.",

keywords = "Anti-tumor immune response, CTLA-4, Immune checkpoints, Immunotherapy, PD-1, PD-L1",

author = "Anand Rotte and Gabriella D'Orazi and Madhuri Bhandaru",

year = "2018",

month = oct,

day = "30",

doi = "10.1186/s13046-018-0937-6",

language = "English",

volume = "37",

journal = "Journal of Experimental and Clinical Cancer Research",

issn = "0392-9078",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Nobel committee honors tumor immunologists

AU - Rotte, Anand

AU - D'Orazi, Gabriella

AU - Bhandaru, Madhuri

PY - 2018/10/30

Y1 - 2018/10/30

N2 - This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body's immune system to attack cancer. Their studies have led to the development of an entire class of drugs that hopefully will bring lasting remissions to many patients who had run out of options.

AB - This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body's immune system to attack cancer. Their studies have led to the development of an entire class of drugs that hopefully will bring lasting remissions to many patients who had run out of options.

KW - Anti-tumor immune response

KW - CTLA-4

KW - Immune checkpoints

KW - Immunotherapy

KW - PD-1

KW - PD-L1

UR - http://www.scopus.com/inward/record.url?scp=85055627847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055627847&partnerID=8YFLogxK

U2 - 10.1186/s13046-018-0937-6

DO - 10.1186/s13046-018-0937-6

M3 - Editorial

C2 - 30376854

AN - SCOPUS:85055627847

VL - 37

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

SN - 0392-9078

IS - 1

ER -

Nobel committee honors tumor immunologists

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this